You are here

CureVac

Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra

Novartis inks 3rd COVID-19 production pact, this time for Roche's arthritis med Actemra

Fierce Pharma

Flag link:

CureVac’s COVID-19 vaccine shows protection against South Africa variant in preclinical study

CureVac’s COVID-19 vaccine shows protection against South Africa variant in preclinical study

Biopharma Reporter

B.1.351 variant

COVID-19 variants

Flag link:

Novartis pairs up with CureVac to help drive Covid-19 shot production but may miss the show in the US, EU

Novartis pairs up with CureVac to help drive Covid-19 shot production but may miss the show in the US, EU

Endpoints

drug manufacturing

Flag link:

CureVac's COVID vaccine enters EMA's rolling review

CureVac's COVID vaccine enters EMA's rolling review

RAPS.org

Flag link:

Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production

Pharma Rivals Step Up to Assist with COVID-19 Vaccine Production

Xtalks

drug manufacturing

Flag link:

GSK/CureVac target new COVID variants with next-gen shot

GSK/CureVac target new COVID variants with next-gen shot

Pharmaforum

Flag link:

Bayer agrees to help CureVac produce coronavirus vaccine

Bayer agrees to help CureVac produce coronavirus vaccine

BioPharma Dive

Flag link:

JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran

JPM: CureVac's new pharma partner Bayer says its COVID-19 vaccine not just an also-ran

Fierce Biotech

Flag link:

Biopharma Companies Entering 2021 With New Collabs, Partnerships

Biopharma Companies Entering 2021 With New Collabs, Partnerships

BioSpace

Dewpoint Therapeutics

Nurix Therapeutics

Flag link:

mRNA latecomer CureVac recruits Bayer to speed COVID-19 vaccine to market

mRNA latecomer CureVac recruits Bayer to speed COVID-19 vaccine to market

Fierce Pharma

Flag link:

CureVac Launches Specialized Phase 3 Clinical Trial of Coronavirus Vaccine Candidate

CureVac Launches Specialized Phase 3 Clinical Trial of Coronavirus Vaccine Candidate

Motley Fool

clinical trials

Flag link:

CureVac starts pivotal late stage trial for its mRNA COVID-19 vaccine candidate

CureVac starts pivotal late stage trial for its mRNA COVID-19 vaccine candidate

Biopharma Reporter

clinical trials

Flag link:

CureVac inks manufacturing deal with Wacker for its COVID-19 vaccine candidate

CureVac inks manufacturing deal with Wacker for its COVID-19 vaccine candidate

Biopharma Reporter

Flag link:

CureVac flags its COVID-19 vaccine as being suitable for standard refrigeration

CureVac flags its COVID-19 vaccine as being suitable for standard refrigeration

Biopharma Reporter

Flag link:

CureVac climbs on vaccine data despite tolerability questions

CureVac climbs on vaccine data despite tolerability questions

Fierce Biotech

clinical trials

Flag link:

CureVac posts an upbeat take on interim PhI Covid-19 vaccine results, with a pivotal study looming. But you'll have to wait on data

CureVac posts an upbeat take on interim PhI Covid-19 vaccine results, with a pivotal study looming. But you'll have to wait on data

Endpoints

clinical trials

Flag link:

CureVac Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate CVnCoV

CureVac Reports Positive Preclinical Data for its COVID-19 Vaccine Candidate CVnCoV

Drugs.com

Flag link:

You've met Moderna, BioNTech and Curevac. Now meet Kernal Bio, the startup working on mRNA 2.0

You've met Moderna, BioNTech and Curevac. Now meet Kernal Bio, the startup working on mRNA 2.0

Fierce Biotech

Moderna Therapeutics

Flag link:

BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fund

BioNTech, CureVac claim bulk of Germany’s €750m COVID-19 vaccines fund

Pharmaforum

Flag link:

CureVac in 'advanced' talks with EU to supply 225M coronavirus vaccine doses

CureVac in 'advanced' talks with EU to supply 225M coronavirus vaccine doses

Fierce Pharma

Flag link:

Pages